Source: Heart Rhythm. Conference titles: Annual Scientific Sessions of the Heart Rhythm Society. Unidade: FM
Subjects: TROMBOSE (PREVENÇÃO E CONTROLE), FATORES DE RISCO, ESTUDOS PROSPECTIVOS
ABNT
COSTA, Roberto et al. Randomized placebo controlled study of warfarin for the prevention of transvenous lead associated thrombosis in righ risk patients. Heart Rhythm. New York: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2008APA
Costa, R., Silva, K. R., Rached, R. A., Martinelli Filho, M., Tamaki, W. T., Crevelari, E. S., et al. (2008). Randomized placebo controlled study of warfarin for the prevention of transvenous lead associated thrombosis in righ risk patients. Heart Rhythm. New York: Faculdade de Medicina, Universidade de São Paulo.NLM
Costa R, Silva KR, Rached RA, Martinelli Filho M, Tamaki WT, Crevelari ES, Carnevale FC, Nasser F, Kwang WT, Moreira LFP, Stolf NAG. Randomized placebo controlled study of warfarin for the prevention of transvenous lead associated thrombosis in righ risk patients. Heart Rhythm. 2008 ; 5( 5S): S27.[citado 2024 nov. 11 ]Vancouver
Costa R, Silva KR, Rached RA, Martinelli Filho M, Tamaki WT, Crevelari ES, Carnevale FC, Nasser F, Kwang WT, Moreira LFP, Stolf NAG. Randomized placebo controlled study of warfarin for the prevention of transvenous lead associated thrombosis in righ risk patients. Heart Rhythm. 2008 ; 5( 5S): S27.[citado 2024 nov. 11 ]